Page last updated: 2024-11-05

tolazoline and Pulmonary Disease, Chronic Obstructive

tolazoline has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Islami, H1
Veseli, A1
Behluli, E1
Morina, N1

Other Studies

1 other study available for tolazoline and Pulmonary Disease, Chronic Obstructive

ArticleYear
Importance of the adrenergic nerve system in the response of gases in the arterial blood following the provoked bronchospasm.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2012, Volume: 66, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Adul

2012